Menopausal hormone therapy and women's health: An umbrella review

GQ Zhang, JL Chen, Y Luo, MB Mathur… - PLoS …, 2021 - journals.plos.org
Background There remains uncertainty about the impact of menopausal hormone therapy
(MHT) on women's health. A systematic, comprehensive assessment of the effects on …

Management of menopause: a view towards prevention

RA Lobo, A Gompel - The Lancet Diabetes & Endocrinology, 2022 - thelancet.com
Women spend approximately one-third of their lives with menopause, which occurs around
50 years of age. It is now appreciated that several important metabolic and cardiovascular …

Hormone-replacement therapy: current thinking

RA Lobo - Nature Reviews Endocrinology, 2017 - nature.com
For several decades, the role of hormone-replacement therapy (HRT) has been debated.
Early observational data on HRT showed many benefits, including a reduction in coronary …

Metabolic disorders in menopause

HG Jeong, H Park - Metabolites, 2022 - mdpi.com
Menopause is an aging process and an important time equivalent to one-third of a woman's
lifetime. Menopause significantly increases the risk of cardiometabolic diseases, such as …

Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial

LL Schierbeck, L Rejnmark, CL Tofteng, L Stilgren… - Bmj, 2012 - bmj.com
Objective To investigate the long term effect of hormone replacement therapy on
cardiovascular outcomes in recently postmenopausal women. Design Open label …

Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review

CG Streed Jr, O Harfouch, F Marvel… - Annals of internal …, 2017 - acpjournals.org
Recent reports estimate that 0.6% of adults in the United States, or approximately 1.4 million
persons, identify as transgender. Despite gains in rights and media attention, the reality is …

Secondary stroke prevention

GJ Hankey - The Lancet Neurology, 2014 - thelancet.com
Survivors of stroke and transient ischaemic attacks are at risk of a recurrent stroke, which is
often more severe and disabling than the index event. Optimum secondary prevention of …

Prevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case–control study

K Wierckx, E Elaut, E Declercq… - European journal of …, 2013 - academic.oup.com
Objective This study evaluated the short-and long-term cardiovascular-and cancer-related
morbidities during cross-sex hormone therapy in a large sample of trans persons. Subjects …

Long-term evaluation of cross-sex hormone treatment in transsexual persons

K Wierckx, S Mueller, S Weyers… - The journal of sexual …, 2012 - academic.oup.com
Introduction Long-term effects and side effects of cross-sex hormone treatment in
transsexual persons are not well known. Aim The aim of this study is to describe the effects …

Migraine headache and ischemic stroke risk: an updated meta-analysis

JT Spector, SR Kahn, MR Jones, M Jayakumar… - The American journal of …, 2010 - Elsevier
BACKGROUND: Observational studies, including recent large cohort studies that were
unavailable for prior meta-analysis, have suggested an association between migraine …